This $11,975,099 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to sustain Lesotho's HIV response. The key objectives are to prevent new HIV infections in girls and young women, and strengthen the well-being of vulnerable children and adolescents, especially those living with HIV. The award supports a range of interventions delivered through sub-awards to local NGOs in Lesotho....
This $1,973,576 Project Grant was awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to the University of Botswana. The grant will fund the development and testing of new PrEP (pre-exposure prophylaxis) implementation strategies targeting the general population in Botswana. Specifically, the project aims to leverage Botswana's national ART (antiretroviral therapy) program infrastructure to pilot a PrEP delivery strategy for...
This federal Cooperative Agreement award of $10,780,323 from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas program (CFDA 98.001) is for the "USAID SUSTAINING EPIDEMIC CONTROL THROUGH UNIFIED PREVENTION (SECURE) ACTIVITY" in Lesotho. The primary awardee, Family Health International (FHI 360), will deliver a range of public health services and technical assistance to support HIV/AIDS prevention and control in Lesotho. Key...
This Cooperative Agreement award from the U.S. Department of State's Bureau of African Affairs, provided under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029), supports a community-led monitoring initiative to improve the quality of HIV care services in Zambia. The $104,988 award, granted on March 18, 2024, will enable the recipient organization, Family Development Initiatives LIMITED, to train local community members to collect client feedback on...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program provides $2,100,000 over the period of January 1, 2025 to December 31, 2029. The purpose of this project is to increase the utilization of quality HIV prevention and treatment services in Tanzania by implementing community-led monitoring activities in close collaboration with the Government of Tanzania. The project will...
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $113,400 to the Botswana Harvard Health Partnership over a 5-year period beginning September 1, 2024. The award will support the development of an HIV cure research program in Botswana, with a focus on understanding HIV persistence and potential for viral control among adolescents who were perinatally infected and have been on long-term antiretroviral therapy since...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), funded under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to determine the effect of integrating sexually transmitted infection (STI) testing with expanded pre-exposure prophylaxis (PrEP) options on PrEP use among pregnant women in Botswana. The $573,475 award, effective from September 2, 2024 to August 31, 2029, will support a randomized trial to evaluate...
The U.S. Agency for International Development (USAID) awarded a $365,253 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to the National Institute Community Development And Management (Nicdam), a non-profit organization based in South Africa. The "CHILDREN, ADOLESCENTS AND FAMILIES IN THE HIV EPIDEMIC (CAFHE) IN THE FREE STATE" program will run from November 2024 to November 2029. The Cooperative Agreement will fund Nicdam's...
The U.S. Agency for International Development (USAID) awarded a $463,364 Cooperative Agreement under its Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program to Choice Trust, a non-profit organization in South Africa. The award, effective from October 1, 2024 to September 30, 2029, will fund comprehensive health and social service interventions focused on HIV/AIDS prevention, gender-based violence reduction, and teenage pregnancy prevention programs in the Limpopo...
The U.S. Agency for International Development (USAID) awarded a $1,674,336 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to support the locally led coordination, management, and implementation of comprehensive HIV and related health and social services to attain and sustain HIV epidemic control in Eswatini. The three-year award, running from Oct 1, 2024 to Sep 30, 2027, will be implemented by the National Emergency Response Council...